572
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Investigation of the biological activity of methanol extract from Eremostachys labiosa Bunge

, , , &
Pages 578-585 | Received 28 Jul 2013, Accepted 20 Oct 2013, Published online: 29 Nov 2013

Figures & data

Figure 1. Growth-inhibitory effect of ELM (10–500 µg/ml) on different cancer and normal cell lines was shown as growth-inhibitory percent.

Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control, tested by ANOVA test.

Figure 1. Growth-inhibitory effect of ELM (10–500 µg/ml) on different cancer and normal cell lines was shown as growth-inhibitory percent.Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control, tested by ANOVA test.

Table 1. Concentrations producing 50% growth inhibition (IC50) of the ELM on different cancer cell lines.

Figure 2. Evaluation of nitric oxide production by J774A.1 macrophages stimulated for 24 h with LPS alone or in combination with 10–400 mg/ml of ELM.

Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control, tested by ANOVA test.

Figure 2. Evaluation of nitric oxide production by J774A.1 macrophages stimulated for 24 h with LPS alone or in combination with 10–400 mg/ml of ELM.Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 compared to control, tested by ANOVA test.
Figure 3. Leishmanicidal activity of ELM (10–500 µg/ml) on promastigote forms of L. major was shown as percent of leishmanicidal rate.

Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group, tested by ANOVA test.

Figure 3. Leishmanicidal activity of ELM (10–500 µg/ml) on promastigote forms of L. major was shown as percent of leishmanicidal rate.Note: Data were expressed as mean ± SD. *P < 0.05, **P < 0.01, ***P < 0.001 vs. control group, tested by ANOVA test.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.